Tag: licensing
-
Biotech Licenses Cell Research for Ebola Treatments
8 January 2015. H&P Labs, a biotechnology company in Montreal, is licensing research on cell proteins at a lab affliated with Harvard University to develop into treatments for Ebola. Financial details of the agreement were not disclosed. The current Ebola outbreak in Africa that began in March 2014 totals 20,747 cases resulting in 8,235 deaths,…
-
Novartis Licensing Biotechs’ Gene-Editing Technologies
7 January 2015. Pharmaceutical maker Novartis is licensing technologies from two biotechnology companies that enable the editing of human genomes to cure disease. Financial details of the agreements with Caribou Biosciences Inc. in Berkeley, California and Intellia Therapeutics in Cambridge, Massachusetts were not disclosed, but involve equity investments, initial payments and research support, and milestone…
-
Amgen, Kite Pharma Partner on Personal Cancer Immunotherapy
5 January 2014. The biotechnology companies Amgen and Kite Pharma are developing personalized cancer treatments harnessing the immune system in a deal combining Amgen’s targets with Kite Pharma’s cell therapies. The agreement is expected to bring up to $525 million in milestone payments plus sales royalties to each company, as well as an upfront payment…
-
Early Trial Underway Testing Brain Cancer Drug
24 December 2014. Kinex Pharmaceuticals, a developer of cancer therapies, began an early-stage clinical trial of an experimental treatment for tumors of support cells in the brain. The Buffalo, New York biotechnology company says the first patient received the drug code-named KX2-361 in the trial taking place at Roswell Park Cancer Institute, also in Buffalo,…
-
Lilly, Biotech Partner on Fast-Acting Insulin Analog
19 December 2014. The pharmaceutical company Eli Lilly and Company and biotechnology company Adocia are collaborating on commercial development of Adocia’s fast-acting synthetic insulin product. Adocia, based in Lyon, France, can gain as much as $570 million in the deal, not counting royalties on future sales. Adocia develops enhanced formulations of protein-based therapies either on…
-
Janssen, Biotech Partner on Drug Delivery Technology
17 December 2014. Halozyme Therapeutics, a biotechnology company in San Diego, is licensing its drug delivery technology for under-the-skin injections to Janssen Biotech, one of the Janssen Pharmaceutical companies and a division of Johnson & Johnson. The deal is expected to bring Halozyme up to $581 million in initial and milestone payments. Halozyme develops synthetic…
-
Spin-Off Building Simplifed Signal Processing Connections
16 December 2014. An engineering lab at Columbia University in New York is spinning off a new company aiming to design simpler connections between analog and digital signals as systems get smaller and performance becomes more demanding. Seamless Devices Inc., founded by electrical engineering professor Peter Kinget and former graduate student Jayanth Kuppambatti, began in…
-
Pfizer, Opko Partner on Growth Hormone Drug
16 December 2014. The pharmaceutical company Pfizer is licensing an engineered compound to treat human growth hormone deficiency in adults and children from Opko Health Inc., a provider of therapeutics and diagnostics. The deal has a potential value to Opko of $570 million, plus royalties from sales. Opko Health, based in Miami, offers drugs and…
-
Pfizer, Biotech Partner on Hemophilia B Gene Therapy
8 December 2014. Spark Therapeutics, a biotechnology firm in Philadelphia, is collaborating with the pharmaceutical company Pfizer to commercialize Spark’s gene therapy technology as a treatment for hemophilia B. Spark Therapeutics can gain as much as $280 million in the deal that involves sharing worldwide rights to Spark’s technology for hemophilia B with Pfizer. Hemophilia…
-
Brain Sensor Designed for Wireless Connections
5 December 2014. Engineers and neuroscientists at Brown University in Providence designed and tested with animals a sensor to monitor brain activity for wirelessly transmitting high volumes of data. The team led by Brown engineering and physics professor Arto Nurmikko — with colleagues from Brown and labs at other universities and companies in the U.S.,…